TLC D-99 and Ifosfamide in Metastatic Soft Tissue Sarcoma Patients
Status:
Completed
Trial end date:
2009-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the maximum tolerated dose of the TLC D-99 combined
with ifosfamide and then the efficacy of this combination in terms of overall response rate,
time to progression and time of response